Package 71610-899-53

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 71610-899-53
Digits Only 7161089953
Product NDC 71610-899
Description

60 TABLET in 1 BOTTLE (71610-899-53)

Marketing

Marketing Status
Marketed Since 2025-04-15
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "334e57bd-f2d0-f7d1-e063-6294a90ac4c4", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993691"], "spl_set_id": ["334e5635-e4cc-cf2a-e063-6294a90ae1e1"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-899-53)", "package_ndc": "71610-899-53", "marketing_start_date": "20250415"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-899-60)", "package_ndc": "71610-899-60", "marketing_start_date": "20250415"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-899-80)", "package_ndc": "71610-899-80", "marketing_start_date": "20250415"}], "brand_name": "Bupropion Hydrochloride", "product_id": "71610-899_334e57bd-f2d0-f7d1-e063-6294a90ac4c4", "dosage_form": "TABLET", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71610-899", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA206975", "marketing_category": "ANDA", "marketing_start_date": "20250130", "listing_expiration_date": "20261231"}